Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics

Levine, 2016, Evolving approaches in research and care for ovarian cancers, a report from the national academies of sciences, engineering and medicine, JAMA, 315, 1943, 10.1001/jama.2016.2640 Alsop, 2012, BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group, J. Clin. Oncol., 30, 2654, 10.1200/JCO.2011.39.8545 Ledermann, 2012, Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer, N. Engl. J. Med., 366, 1382, 10.1056/NEJMoa1105535 Scott, 2015, Poly (ADP-ribose) polymerase inhibitors: recent advances and future development, J. Clin. Oncol., 33, 1397, 10.1200/JCO.2014.58.8848 Moore, 2014, SOLO1 and SOLO2: Randomised phase III trials of olaparib in patients (pts) with ovarian cancer and a BRCA1/2 mutation (BRCAm), J. Clin. Oncol., 32 Gonzalez-Martin, 2016, A randomised, double-blind phase III trial of naraparib maintenance treatment in patients with HRD+ advanced ovarian cancer after response to front-line platinum-based chemotherapy, J. Clin. Oncol., 34 Meiser, 2012, There is no decision to make: experiences and attitudes towards treatment-focused genetic testing among women diagnosed with ovarian cancer, Gynecol. Oncol., 124, 153, 10.1016/j.ygyno.2011.09.040 Ricci, 2015, Referral of ovarian cancer patients for genetic counselling by oncologists: need for improvement, Public Health Genomics, 18, 225, 10.1159/000431352 Cohen, 2016, Impact of clinical genetics attendance at a gynecologic oncology tumor board on referrals for genetic counseling and BRCA mutation testing, Int. J. Gynecol. Cancer, 26, 892, 10.1097/IGC.0000000000000689 Schwartz, 2014, Randomised non-inferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer, J. Clin. Oncol., 32, 618, 10.1200/JCO.2013.51.3226 George, 2016, Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients, Sci. Rep., 13, 29506, 10.1038/srep29506 Percival, 2016, The integration of BRCA testing into oncology clinics, Br. J. Nurs., 25, 690, 10.12968/bjon.2016.25.12.690 Ledermann, 2016, Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial, Lancet Oncol., 17, 1579, 10.1016/S1470-2045(16)30376-X Swisher, 2016, Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial, Lancet Oncol. Douma, 2016, Non-genetic health professionals' attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer, Fam. Cancer, 15, 341, 10.1007/s10689-015-9852-6 Son, 2014, Completeness of pedigree and family cancer history for ovarian cancer patients, J. Gynecol. Oncol., 25, 342, 10.3802/jgo.2014.25.4.342 Rogers, 1984, The semi-structured genogram interview, Fam. Syst. Med., 2, 176, 10.1037/h0091655 Wilikins-Haug, 2000, Obstetrician-gynecologists' opinions and attitudes on the role of genetics in women's health, J. Womens Health Gend. Based Med., 9, 873, 10.1089/152460900750020900 Eccles, 2015, Understanding of BRCA VUS genetic results by breast cancer specialists, BMC Cancer, 15, 936, 10.1186/s12885-015-1934-1 Gleeson, 2013, Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing, Oncol. Nurs. Forum, 40, 275, 10.1188/13.ONF.40-03AP Febbraro, 2015, Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals, Gynecol. Oncol., 138, 109, 10.1016/j.ygyno.2015.04.029 Petzel, 2013, Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic, J. Genet. Couns., 22, 662, 10.1007/s10897-013-9598-y